These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 8445290)
1. Autoantibody to von Willebrand factor in systemic lupus erythematosus. Soff GA; Green D J Lab Clin Med; 1993 Mar; 121(3):424-30. PubMed ID: 8445290 [TBL] [Abstract][Full Text] [Related]
2. Systemic lupus erythematosus complicated by acquired von Willebrand's syndrome. Hong S; Lee J; Chi H; Lee C; Nah S; Kim Y; Oh J; Moon H; Yoo B Lupus; 2008 Sep; 17(9):846-8. PubMed ID: 18755868 [TBL] [Abstract][Full Text] [Related]
3. Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management. Michiels JJ; Budde U; van der Planken M; van Vliet HH; Schroyens W; Berneman Z Best Pract Res Clin Haematol; 2001 Jun; 14(2):401-36. PubMed ID: 11686107 [TBL] [Abstract][Full Text] [Related]
4. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content. Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944 [TBL] [Abstract][Full Text] [Related]
5. Mapping and functional studies of two alloantibodies developed in patients with type 3 von Willebrand disease. Tout H; Obert B; Houllier A; Fressinaud E; Rothschild C; Meyer D; Girma JP Thromb Haemost; 2000 Feb; 83(2):274-81. PubMed ID: 10739386 [TBL] [Abstract][Full Text] [Related]
6. Three cases of acquired von Willebrand disease associated with systemic lupus erythematosus. Viallard JF; Pellegrin JL; Vergnes C; Borel-Derlon A; Clofent-Sanchez G; Nurden AT; Leng B; Nurden P Br J Haematol; 1999 May; 105(2):532-7. PubMed ID: 10233433 [TBL] [Abstract][Full Text] [Related]
7. Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease. Caron C; Hilbert L; Vanhoorelbeke K; Deckmyn H; Goudemand J; Mazurier C Br J Haematol; 2006 Jun; 133(6):655-63. PubMed ID: 16704443 [TBL] [Abstract][Full Text] [Related]
8. Posttransfusion anaphylactic reactions in a patient with severe von Willebrand disease: role of complement and alloantibodies to von Willebrand factor. Bergamaschini L; Mannucci PM; Federici AB; Coppola R; Guzzoni S; Agostoni A J Lab Clin Med; 1995 Mar; 125(3):348-55. PubMed ID: 7897302 [TBL] [Abstract][Full Text] [Related]
9. Comparison of two von Willebrand factor collagen-binding assays with different binding affinities for low, medium, and high multimers of von Willebrand factor. Neugebauer BM; Goy C; Budek I; Seitz R Semin Thromb Hemost; 2002 Apr; 28(2):139-48. PubMed ID: 11992237 [TBL] [Abstract][Full Text] [Related]
10. A sensitive ELISA for von Willebrand factor (vWf:Ag). Ingerslev J Scand J Clin Lab Invest; 1987 Apr; 47(2):143-9. PubMed ID: 3107116 [TBL] [Abstract][Full Text] [Related]
11. Comparative study on collagen-binding enzyme-linked immunosorbent assay and ristocetin cofactor activity assays for detection of functional activity of von Willebrand factor. Turecek PL; Siekmann J; Schwarz HP Semin Thromb Hemost; 2002 Apr; 28(2):149-60. PubMed ID: 11992238 [TBL] [Abstract][Full Text] [Related]
12. [Acquired von Willebrand syndrome with autoimmune hemolytic anemia]. Sakai M; Shima M; Izumi Y; Shirahata A Rinsho Ketsueki; 2004 Mar; 45(3):223-7. PubMed ID: 15103936 [TBL] [Abstract][Full Text] [Related]
13. A multispecies enzyme-linked immunosorbent assay for von Willebrand's factor. Benson RE; Catalfamo JL; Dodds WJ J Lab Clin Med; 1992 Apr; 119(4):420-7. PubMed ID: 1583394 [TBL] [Abstract][Full Text] [Related]
14. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications. Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235 [TBL] [Abstract][Full Text] [Related]
15. Immune-mediated etiology of acquired von Willebrand syndrome in systemic lupus erythematosus and in benign monoclonal gammopathy: therapeutic implications. Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; Budde U; van Vliet HH Semin Thromb Hemost; 2006 Sep; 32(6):577-88. PubMed ID: 16977568 [TBL] [Abstract][Full Text] [Related]
16. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease. Geisen U; Heilmann C; Beyersdorf F; Benk C; Berchtold-Herz M; Schlensak C; Budde U; Zieger B Eur J Cardiothorac Surg; 2008 Apr; 33(4):679-84. PubMed ID: 18282712 [TBL] [Abstract][Full Text] [Related]
17. Abnormal antigenic reactivity of factor VIII/von Willebrand factor subunit in variants of von Willebrand's disease. Girma JP; Pietu G; Lavergne JM; Meyer D; Larrieu MJ J Lab Clin Med; 1982 Apr; 99(4):481-94. PubMed ID: 6174657 [TBL] [Abstract][Full Text] [Related]
18. Acquired von Willebrand's syndrome: a single institution experience. Kumar S; Pruthi RK; Nichols WL Am J Hematol; 2003 Apr; 72(4):243-7. PubMed ID: 12666134 [TBL] [Abstract][Full Text] [Related]
19. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio. Gadisseur A; Berneman Z; Schroyens W; Michiels JJ Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359 [TBL] [Abstract][Full Text] [Related]
20. Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease. Budde U; Metzner HJ; Müller HG Semin Thromb Hemost; 2006 Sep; 32(6):626-35. PubMed ID: 16977573 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]